Loading...
Loading...
KA| Name | Value |
|---|---|
| Revenues | 281.0K |
| Cost of Revenue | 179.0K |
| Gross Profit | 102.0K |
| Operating Expense | 6,767.0K |
| Operating I/L | -6,486.0K |
| Other Income/Expense | 6.0K |
| Interest Income | 23.0K |
| Pretax | -6,480.0K |
| Income Tax Expense | -12.0K |
| Net Income/Loss | -6,468.0K |
Kineta, Inc. is a clinical stage biotechnology company specializing in the development of immunotherapies for oncology, neuroscience, and biodefense. The company generates revenue through strategic partnerships with industry leaders such as Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Its immunotherapy products cater to private, government, and industry partners, positioning Kineta, Inc. as a key player in the biotechnology sector.
